Literature DB >> 2846869

Induction of anchorage-independent growth of human embryonic fibroblasts with a deletion in the short arm of chromosome 11 by human papillomavirus type 16 DNA.

H L Smits1, E Raadsheer, I Rood, S Mehendale, R M Slater, J van der Noordaa, J ter Schegget.   

Abstract

Human embryonic fibroblasts with a large deletion (11p11.11p15.1) in the short arm of one chromosome 11 (del-11 cells) appeared to be susceptible to transformation by early human papillomavirus type 16 (HPV-16) DNA, whereas diploid human embryonic fibroblasts were not. This difference in susceptibility might be explained by the absence of a tumor suppressor gene located within the deleted part on the short arm of chromosome 11. The presence of abundant viral early-gene transcripts in transformed cells suggests that transformation was induced by an elevated level of an HPV-16 early-gene product(s). The low transcriptional activity of HPV-16 in diploid cells may indicate that cellular genes affect viral transcription. Interruption of the HPV-16 E2 early open reading frame is probably required for high-level HPV-16 early-gene expression driven from the homologous enhancer-promoter region.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846869      PMCID: PMC253564     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  AIDS in West Germany.

Authors:  J L'age-Stehr; R Kunze; M A Koch
Journal:  Lancet       Date:  1983-12-10       Impact factor: 79.321

3.  Diazotizable arylamine cellulose papers for the coupling and hybridization of nucleic acids.

Authors:  B Seed
Journal:  Nucleic Acids Res       Date:  1982-03-11       Impact factor: 16.971

4.  A statistical model of the natural history of cervical neoplastic disease: the duration of carcinoma in situ.

Authors:  B A Barron; M C Cahill; R M Richart
Journal:  Gynecol Oncol       Date:  1978-04       Impact factor: 5.482

5.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines.

Authors:  C C Baker; W C Phelps; V Lindgren; M J Braun; M A Gonda; P M Howley
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

6.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

7.  Nonrandom chromosome changes in carcinoma of the cervix uteri. I. Nine near-diploid tumors.

Authors:  N B Atkin; M C Baker
Journal:  Cancer Genet Cytogenet       Date:  1982-11

8.  Cytogenetic features of human neuroblastomas and cell lines.

Authors:  G M Brodeur; A A Green; F A Hayes; K J Williams; D L Williams; A A Tsiatis
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

9.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  6 in total

1.  Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells.

Authors:  F X Bosch; E Schwarz; P Boukamp; N E Fusenig; D Bartsch; H zur Hausen
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

Review 2.  Use of the polymerase chain reaction to study the relationship between human papillomavirus infections and cervical cancer.

Authors:  W J Melchers; H C Claas; W G Quint
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

3.  The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.

Authors:  B A Bernard; C Bailly; M C Lenoir; M Darmon; F Thierry; M Yaniv
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids.

Authors:  F Rösl; M Lengert; J Albrecht; K Kleine; R Zawatzky; B Schraven; H zur Hausen
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

5.  The 55 kDa regulatory subunit of protein phosphatase 2A plays a role in the activation of the HPV16 long control region in human cells with a deletion in the short arm of chromosome 11.

Authors:  P H Smits; H L Smits; R P Minnaar; B A Hemmings; R E Mayer-Jaekel; R Schuurman; J van der Noordaa; J ter Schegget
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

6.  Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions.

Authors:  F Rösl; T Achtstätter; T Bauknecht; K J Hutter; G Futterman; H zur Hausen
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.